US5502187A
(en)
*
|
1992-04-03 |
1996-03-26 |
The Upjohn Company |
Pharmaceutically active bicyclic-heterocyclic amines
|
EP0723533A1
(en)
|
1993-10-12 |
1996-07-31 |
The Du Pont Merck Pharmaceutical Company |
1n-alkyl-n-arylpyrimidinamines and derivatives thereof
|
US6342501B1
(en)
|
1994-02-25 |
2002-01-29 |
The Regents Of The University Of Michigan |
Pyrrolo[2,3-d] pyrimidines as antiviral agents
|
MX9605218A
(es)
*
|
1994-04-29 |
1997-10-31 |
Pfizer |
Amidas aciclicas y ciclicas novedosas como mejoradores de liberacion de neurotransmisores.
|
ES2109796T3
(es)
*
|
1994-05-03 |
1998-01-16 |
Ciba Geigy Ag |
Derivados de pirrolopirimidilo con efecto antiproliferante.
|
TW530047B
(en)
*
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
US5646152A
(en)
*
|
1994-06-15 |
1997-07-08 |
Pfizer Inc. |
Methods of administering CRF antagonists
|
MX9606504A
(es)
*
|
1994-06-16 |
1997-03-29 |
Pfizer |
Compuestos biciclicos.
|
EP0729758A3
(en)
*
|
1995-03-02 |
1997-10-29 |
Pfizer |
Pyrazolopyrimidines and pyrrolopyrimidines to treat neuronal disorders and other diseases
|
US5804685A
(en)
*
|
1995-06-07 |
1998-09-08 |
Neurogen Corporation |
Deazapurine derivatives: a new class of CRF1 specific ligands
|
US5644057A
(en)
*
|
1995-05-12 |
1997-07-01 |
Neurogen Corporation |
Deazapurine derivatives; a new class of CRF1 specific ligands
|
EP0770080B1
(en)
*
|
1995-05-12 |
1999-07-14 |
Neurogen Corporation |
Novel deazapurine derivatives; a new class of crf1 specific ligands
|
US7125880B1
(en)
|
1995-06-06 |
2006-10-24 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
ES2203642T3
(es)
*
|
1995-06-07 |
2004-04-16 |
Pfizer Inc. |
Derivados de pirimidina heterociclicos con anillos condensados.
|
US6143749A
(en)
*
|
1995-06-07 |
2000-11-07 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
US6395733B1
(en)
|
1995-06-07 |
2002-05-28 |
Pfizer Inc |
Heterocyclic ring-fused pyrimidine derivatives
|
US5665721A
(en)
*
|
1995-06-07 |
1997-09-09 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
US5955613A
(en)
*
|
1995-10-13 |
1999-09-21 |
Neurogen Corporation |
Certain pyrrolopyridine derivatives; novel CRF1 specific ligands
|
AU738304B2
(en)
|
1995-10-13 |
2001-09-13 |
Neurogen Corporation |
Certain pyrrolopyridine derivatives; novel CRF 1 specific ligands
|
DE69628804T2
(de)
*
|
1995-12-08 |
2003-12-18 |
Pfizer Inc., New York |
Substitutierte heterozyclische Derivate als CRF Antagonisten
|
US6992188B1
(en)
|
1995-12-08 |
2006-01-31 |
Pfizer, Inc. |
Substituted heterocyclic derivatives
|
US6664261B2
(en)
|
1996-02-07 |
2003-12-16 |
Neurocrine Biosciences, Inc. |
Pyrazolopyrimidines as CRF receptor antagonists
|
ES2167710T3
(es)
|
1996-02-07 |
2002-05-16 |
Janssen Pharmaceutica Nv |
Tiofenopirimidinas.
|
US6051578A
(en)
*
|
1996-02-12 |
2000-04-18 |
Pfizer Inc. |
Pyrazolopyrimidines for treatment of CNS disorders
|
AU725254B2
(en)
*
|
1996-03-26 |
2000-10-12 |
Du Pont Pharmaceuticals Company |
Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives
|
US6166016A
(en)
*
|
1996-06-06 |
2000-12-26 |
Otsuka Pharmaceutical Factory, Inc. |
Amide derivatives
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
PT915880E
(pt)
*
|
1996-07-24 |
2007-12-31 |
Bristol Myers Squibb Pharma Co |
Azol triazinas e pirimidinas
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
ES2191183T3
(es)
*
|
1996-08-06 |
2003-09-01 |
Pfizer |
Derivados 6,6- o 6,7-biciclicos que contienen pirido o pirimido sustituidos.
|
US5861398A
(en)
*
|
1996-08-26 |
1999-01-19 |
Alanex Corporation |
Benzoperimidine-carboxylic acids and derivatives thereof
|
TW477787B
(en)
*
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
JP2001502300A
(ja)
|
1996-09-16 |
2001-02-20 |
デュポン ファーマシューティカルズ カンパニー |
ピラジノン類およびトリアジノン類およびその誘導体類
|
WO1998023613A1
(en)
|
1996-11-27 |
1998-06-04 |
Pfizer Inc. |
Fused bicyclic pyrimidine derivatives
|
US5723608A
(en)
|
1996-12-31 |
1998-03-03 |
Neurogen Corporation |
3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
|
WO1998035967A2
(en)
*
|
1997-02-18 |
1998-08-20 |
Neurocrine Biosciences, Inc. |
Biazacyclic crf antagonists
|
US5972945A
(en)
*
|
1997-06-13 |
1999-10-26 |
Neurogen Corporation |
2-aminoalkylaminoquinolines; dopamine receptor subtype specific ligands
|
US6313141B1
(en)
|
1997-06-13 |
2001-11-06 |
Neurogen Corporation |
2-aminoalkylaminoquinolines as dopamine D4 ligands
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
US6613777B1
(en)
|
1998-03-06 |
2003-09-02 |
Chen Chen |
CRF antagonistic pyrazolo[4,3-b]pyridines
|
US6147085A
(en)
*
|
1999-04-01 |
2000-11-14 |
Neurogen Corporation |
Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
|
AU3464599A
(en)
*
|
1998-04-02 |
1999-10-25 |
Neurogen Corporation |
Aminoalkyl substituted 9h-pyridino(2,3-b)indole and 9h-pyrimidino(4,5-b)indole derivatives
|
EP1068206A1
(en)
*
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
Aminoalkyl substituted pyrrolo 2,3-b]pyridine and pyrrolo 2,3-d]pyrimidine derivatives: modulators of crf1 receptors
|
WO1999051598A1
(en)
|
1998-04-02 |
1999-10-14 |
Neurogen Corporation |
SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES: SELECTIVE NEUROPEPTIDE y RECEPTOR LIGANDS
|
CA2326319A1
(en)
*
|
1998-04-02 |
1999-10-14 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
|
US6472402B1
(en)
|
1998-04-02 |
2002-10-29 |
Neurogen Corporation |
Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
|
US7799766B2
(en)
*
|
1998-04-08 |
2010-09-21 |
Theta Biomedical Consulting & Development Co., Inc. |
Composition for treating hormonally-dependent cancers
|
US20080153761A1
(en)
*
|
1998-04-08 |
2008-06-26 |
Theoharides Theoharis C |
Compositions for protection against superficial vasodilator flush syndrome, and methods of use
|
US6984667B2
(en)
*
|
1998-04-08 |
2006-01-10 |
Theta Biomedical Consulting And Development Co. |
Synergistic proteoglycan compositions for inflammatory conditions
|
US7906153B2
(en)
*
|
1998-04-08 |
2011-03-15 |
Theta Biomedical Consulting & Development Co., Inc. |
Anti-inflammatory compositions for treating multiple sclerosis
|
US20050220909A1
(en)
*
|
2004-03-30 |
2005-10-06 |
Theoharides Theoharis C |
Composition for protection against superficial vasodilator flush syndrome
|
US6878716B1
(en)
|
1998-06-02 |
2005-04-12 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptor and uses thereof
|
US6686366B1
(en)
|
1998-06-02 |
2004-02-03 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
KR100722194B1
(ko)
*
|
1998-06-02 |
2007-05-29 |
오에스아이 파마슈티컬스, 인코포레이티드 |
피롤로[2,3디]피리미딘 조성물 및 이의 용도
|
ES2196820T3
(es)
|
1998-06-09 |
2003-12-16 |
Neurogen Corp |
Derivados de pirido(2,3-b)indolizina y aza-analogos de la misma; ligandos especificos de crf 1.
|
KR20010080402A
(ko)
*
|
1998-11-12 |
2001-08-22 |
추후기재 |
Crf 수용체 길항제 및 그와 관련된 방법
|
DE69903333T2
(de)
*
|
1998-11-12 |
2003-08-07 |
Neurocrine Biosciences, Inc. |
Crf rezeptor-antagonisten und darauf bezogene methoden
|
US6531475B1
(en)
|
1998-11-12 |
2003-03-11 |
Neurocrine Biosciences, Inc. |
CRF receptor antagonists and methods relating thereto
|
EP1449843A1
(en)
|
1999-03-11 |
2004-08-25 |
Taisho Pharmaceutical Co. Ltd. |
Intermediates for the preparation of carbamoyl tetrahydropyridine derivatives
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
US6387894B1
(en)
|
1999-06-11 |
2002-05-14 |
Pfizer Inc. |
Use of CRF antagonists and renin-angiotensin system inhibitors
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
EP1224187B1
(en)
*
|
1999-09-30 |
2006-02-22 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
CO5271670A1
(es)
|
1999-10-29 |
2003-04-30 |
Pfizer Prod Inc |
Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
|
US6525067B1
(en)
*
|
1999-11-23 |
2003-02-25 |
Pfizer Inc |
Substituted heterocyclic derivatives
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
BR0107662A
(pt)
|
2000-01-18 |
2002-11-19 |
Pfizer Prod Inc |
Antagonistas do fator de liberação de corticotropina
|
WO2001058489A1
(fr)
*
|
2000-02-14 |
2001-08-16 |
Japan Tobacco Inc. |
Agents prophylactiques/therapeutiques contre le stress postoperatoire
|
US6613901B2
(en)
|
2000-03-08 |
2003-09-02 |
Neurogen Corporation |
2-aminoalkylaminoquinolines as dopamine D4 ligands
|
US20060287335A1
(en)
|
2000-11-28 |
2006-12-21 |
Wyeth |
Serotonergic agents for treating sexual dysfunction
|
US20060223824A1
(en)
|
2000-11-28 |
2006-10-05 |
Wyeth |
Serotonergic agents
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
MEP35308A
(en)
*
|
2000-12-01 |
2011-02-10 |
Osi Pharm Inc |
COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF
|
KR100897430B1
(ko)
*
|
2000-12-01 |
2009-05-14 |
오에스아이 파마슈티컬스, 인코포레이티드 |
아데노신 a₁, a₂a 및 a₃ 수용체에 특이적인 화합물및 그의 용도
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
GB0100622D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds V111
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
EP1389618B1
(en)
|
2001-04-27 |
2011-06-15 |
Eisai R&D Management Co., Ltd. |
Pyrazolo 1,5-a pyridines and medicines containing the same
|
CA2446980A1
(en)
*
|
2001-05-14 |
2002-11-21 |
Argyrios G. Arvanitis |
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
|
IL144900A
(en)
|
2001-08-14 |
2013-12-31 |
Neurim Pharma 1991 |
Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
|
US6638981B2
(en)
|
2001-08-17 |
2003-10-28 |
Epicept Corporation |
Topical compositions and methods for treating pain
|
AU2002360436A1
(en)
|
2001-11-30 |
2003-06-17 |
Osi Pharmaceuticals, Inc. |
2-aryl pyrrologpyrimidines for a1 and a3 receptors
|
DE60236458D1
(de)
|
2001-12-20 |
2010-07-01 |
Osi Pharm Inc |
Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
|
CA2471059C
(en)
|
2001-12-20 |
2011-04-26 |
Osi Pharmaceuticals, Inc. |
Pyrimidine a2b selective antagonist compounds, their synthesis and use
|
DE10163991A1
(de)
*
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
Pyrrolo-pyrimidine
|
US7176216B2
(en)
|
2002-10-22 |
2007-02-13 |
Eisai Co., Ltd. |
7-phenylpyrazolopyridine compounds
|
PT1555265E
(pt)
|
2002-10-22 |
2009-05-12 |
Eisai R&D Man Co Ltd |
Compostos de 7-fenil pirazolopiridina
|
GR1004664B
(en)
*
|
2002-11-26 |
2004-09-02 |
Bionature E A Ltd |
The charakteristics and advantages of our invention are illustrated by the following description, methods and results of our research, attached figures and supporting references
|
CA2505788A1
(en)
|
2002-12-13 |
2004-07-01 |
Warner-Lambert Company Llc |
Pregabalin derivatives for the treatment of fibromyalgia and other disorders
|
AR042667A1
(es)
|
2002-12-26 |
2005-06-29 |
Taisho Pharmaceutical Co Ltd |
Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico
|
US20060058217A1
(en)
*
|
2003-01-21 |
2006-03-16 |
White Hillary D |
Compositions and methods for treatment of ovarian cancer
|
EP1615931A1
(en)
|
2003-04-09 |
2006-01-18 |
Biogen Idec MA Inc. |
Triazolopyrazines and methods of making and using the same
|
EP1633756B1
(en)
|
2003-04-09 |
2008-12-24 |
Biogen Idec MA Inc. |
A2a adenosine receptor antagonists
|
WO2004092170A2
(en)
|
2003-04-09 |
2004-10-28 |
Biogen Idec Ma Inc. |
Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
|
US7160888B2
(en)
|
2003-08-22 |
2007-01-09 |
Warner Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
|
RU2006128580A
(ru)
|
2004-01-06 |
2008-02-20 |
Тайсо Фармасьютикал Ко., Лтд. (Jp) |
Производные тиенопиримидина и тиенопиридина, замещенные циклической аминогруппой
|
US8106194B2
(en)
|
2004-01-06 |
2012-01-31 |
Taisho Pharmaceutical Co., Ltd. |
Pyrrolopyrimidine and pyrrolotriazine derivatives
|
CN1926140A
(zh)
*
|
2004-03-05 |
2007-03-07 |
大正制药株式会社 |
吡咯并嘧啶衍生物
|
US7923043B2
(en)
*
|
2004-03-30 |
2011-04-12 |
Theta Biomedical Consulting & Development Co., Inc. |
Method for protecting humans against superficial vasodilator flush syndrome
|
JP2007161585A
(ja)
|
2004-06-25 |
2007-06-28 |
Taisho Pharmaceut Co Ltd |
環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
|
CN101203218A
(zh)
*
|
2005-04-22 |
2008-06-18 |
惠氏公司 |
苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途
|
CN101203216A
(zh)
*
|
2005-04-22 |
2008-06-18 |
惠氏公司 |
二氢苯并呋喃衍生物及其用途
|
CN101163689A
(zh)
*
|
2005-04-22 |
2008-04-16 |
惠氏公司 |
{[(2r)-7-(2,6-二氯苯基)-5-氟-2,3-二氢-1-苯并呋喃-2-基]甲基}胺盐酸盐的晶形
|
TW200718692A
(en)
*
|
2005-04-22 |
2007-05-16 |
Wyeth Corp |
Dihydrobenzofuran derivatives and uses thereof
|
TW200800959A
(en)
|
2005-06-10 |
2008-01-01 |
Wyeth Corp |
Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
|
KR20080105104A
(ko)
*
|
2006-03-24 |
2008-12-03 |
와이어쓰 |
우울증 치료를 위한 신규한 치료학적 병용제
|
EA200870385A1
(ru)
*
|
2006-03-29 |
2009-04-28 |
Фолдркс Фармасьютикалз, Инк. |
Ингибирование токсичности альфа-синуклеина
|
AU2007297481B2
(en)
|
2006-09-20 |
2012-03-08 |
Eli Lilly And Company |
Thiophene pyrazolopyrimidine compounds
|
US8030304B2
(en)
*
|
2006-09-20 |
2011-10-04 |
Eli Lilly And Company |
Thiazole pyrazolopyrimidines CRF1 receptor antagonists
|
CL2008000119A1
(es)
|
2007-01-16 |
2008-05-16 |
Wyeth Corp |
Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
|
EP2522351B1
(en)
*
|
2007-06-13 |
2017-09-06 |
Research Development Foundation |
Treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling
|
EP2254420A4
(en)
|
2008-02-20 |
2012-02-15 |
Targia Pharmaceuticals |
CNS PHARMACEUTICALS AND METHOD FOR THEIR USE
|
JP4654325B2
(ja)
|
2008-04-15 |
2011-03-16 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
3−フェニルピラゾロ[5,1−b]チアゾール化合物
|
US8461389B2
(en)
|
2008-04-18 |
2013-06-11 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
WO2010066629A2
(en)
*
|
2008-12-09 |
2010-06-17 |
F. Hoffmann-La Roche Ag |
Novel azaindoles
|
US9050275B2
(en)
*
|
2009-08-03 |
2015-06-09 |
Theta Biomedical Consulting & Development Co., Inc. |
Methods of screening for and treating autism spectrum disorders and compositions for same
|
US9176146B2
(en)
*
|
2009-08-03 |
2015-11-03 |
Theta Biomedical Consulting & Development Co., Inc. |
Methods of treating autism spectrum disorders and compositions for same
|
AR078521A1
(es)
|
2009-10-08 |
2011-11-16 |
Eisai R&D Man Co Ltd |
Compuesto pirazolotiazol
|
GB201210686D0
(en)
|
2012-06-15 |
2012-08-01 |
Holsboermaschmeyer Neurochemie Gmbh |
V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
LT2958921T
(lt)
|
2013-02-22 |
2017-11-27 |
Pfizer Inc. |
Pirolo[2, 3 -d]pirimidino dariniai, kaip janus kinazės (jak) inhibitoriai
|
GB201310782D0
(en)
|
2013-06-17 |
2013-07-31 |
Max Planck Innovation Gmbh |
Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
|
JP6585158B2
(ja)
|
2014-08-12 |
2019-10-02 |
ファイザー・インク |
ヤヌスキナーゼの阻害に有用なピロロ[2,3−d]ピリミジン誘導体
|
EP3194399B1
(en)
*
|
2014-09-17 |
2019-04-10 |
Pécsi Tudományegyetem |
New agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
|
AU2016297558B2
(en)
*
|
2015-07-20 |
2021-03-25 |
Genzyme Corporation |
Colony stimulating factor-1 receptor (CSF-1R) inhibitors
|
CN110337294B
(zh)
*
|
2016-11-18 |
2022-11-01 |
囊性纤维化基金会 |
作为cftr增效剂的吡咯并嘧啶
|
MX2023001688A
(es)
|
2020-08-12 |
2023-02-22 |
Spruce Biosciences Inc |
Metodos y composiciones para tratar el sindrome de ovario poliquistico.
|
EP4267573A1
(en)
|
2020-12-23 |
2023-11-01 |
Genzyme Corporation |
Deuterated colony stimulating factor-1 receptor (csf-1r) inhibitors
|
US11708372B2
(en)
|
2021-11-19 |
2023-07-25 |
Spruce Biosciences, Inc. |
Crystalline composition of tildacerfont and methods of use and preparation thereof
|